A new technology marks a turning point in the treatment of early-stage breast cancer GammaPod, one of the most advanced innovations in the treatment of
Biocon Biologics Ltd , a fully integrated global biosimilars company and subsidiary of Biocon Ltd announced that the Committee for Medicinal Products for Human Use (CHMP)
Transaction further establishes Norgine’s position as a partner of choice for commercialising rare and specialty pharmaceuticals in Europe Norgine and Theravia announced that they have entered into
Fuel up with free Health Tech Insights
